BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Business

  AFP Imaging Corporation Co-Founder, Donald Rabinovitch, Retires

  September 30, 2009

   · 

  2 min read
• Biotech Bay

  Threshold Pharmaceuticals, Inc. Announces Private Equity Financing of $35 Million

  September 30, 2009

   · 

  4 min read
• Genetown

  Dyax Corp. Announces Pricing of Public Offering of Common Stock

  September 30, 2009

   · 

  1 min read
• Genetown

  Phase Forward to Present at the William Blair Emerging Growth Stock Conference

  September 30, 2009

   · 

  1 min read
• Drug Development

  Can-Fite BioPharma Initiates Preparatory Work for Psoriasis Phase III Trial with CF101

  September 30, 2009

   · 

  1 min read
• Drug Development

  Ardea Biosciences, Inc. to Present Results from a Phase 2a Study of RDEA594 at the 2009 ACR/ARHP Annual Scientific Meeting

  September 30, 2009

   · 

  1 min read
• BioCapital

  Nabi Biopharmaceuticals Land $10 Million for Smoking Cessation Trials

  September 30, 2009

   · 

  1 min read
• Genetown

  Aphios Awarded National Institutes of Health (NIH) ARRA Challenge Grant for Pathogen Inactivation Technology for Blood Products

  September 30, 2009

   · 

  1 min read
• Business

  Aileron Therapeutics Appoints Industry Veteran Diane Jorkasky, M.D., as Company’s Head of Development and Chief Medical Officer

  September 30, 2009

   · 

  1 min read
• Drug Development

  Capstone Therapeutics Announces Completion of Enrollment for Second of Two AZX100 Phase 2 Studies in Keloid Scarring; Phase 2 Study in Shoulder Surgery Scarring Reaches Enrollment Milestone

  September 30, 2009

   · 

  1 min read